Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Apr 15, 2024; 16(4): 1626-1646
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1626
Published online Apr 15, 2024. doi: 10.4251/wjgo.v16.i4.1626
Criteria | Tong et al[37], 2023 | Steele et al[24], 2019 | Nanki et al[23], 2018 | Yan et al[21], 2018 | Li et al[25], 2022 | Kawasaki et al[22], 2020 | Li et al[27], 2023 | Zou et al[26], 2022 |
A clearly stated aim | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Inclusion of consecutive patients | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Prospective collection of data | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Endpoints appropriate to the aim of the study | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Follow-up period appropriate to the aim of the study | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 1 |
Loss to follow up less than 5% | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 1 |
Baseline equivalence of groups | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 |
Adequate statistical analyses | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Total | 16 | 15 | 16 | 16 | 14 | 15 | 15 | 14 |
- Citation: Jiang KL, Wang XX, Liu XJ, Guo LK, Chen YQ, Jia QL, Yang KM, Ling JH. Success rate of current human-derived gastric cancer organoids establishment and influencing factors: A systematic review and meta-analysis. World J Gastrointest Oncol 2024; 16(4): 1626-1646
- URL: https://www.wjgnet.com/1948-5204/full/v16/i4/1626.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i4.1626